| Literature DB >> 36012980 |
Andrea Colizza1, Massimo Ralli1, Arianna Di Stadio2, Francesca Cambria1, Federica Zoccali1, Fabrizio Cialente1, Diletta Angeletti1, Antonio Greco1, Marco de Vincentiis1.
Abstract
BACKGROUND: Open partial horizontal laryngectomies (OPHL) are one of the surgical techniques used for the conservative management of laryngeal cancers. The aims of this study are to analyze the oncological and functional results of a group of patients affected by laryngeal squamous cell carcinoma (LSCC) treated with OPHL, performed using a minimally invasive technique.Entities:
Keywords: anterior myocutaneous flap; laryngeal squamous cell carcinoma; lateral cervical approach; open partial horizontal laryngectomies; penetration aspiration scale
Year: 2022 PMID: 36012980 PMCID: PMC9410219 DOI: 10.3390/jcm11164741
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Figure 1(A) CT scan of laryngeal carcinoma of the left vocal fold. (B) Post-operative CT scan of new laryngeal anatomy.
Demographics, surgical and oncological features of patients enrolled.
| ID Case | Sex/Age | Main Symptoms | Site/Subsites | cTNM | Surgery | Surgical Time (Minutes) | pTNM | PO Therapy | FU (Months/Status) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | M/58 | Dysphonia | Glottis/RVC | cT3N0 | OPHL 2B + ARY DX + RSND (II–IV) | 120 | pT3N2a | RT + CT | 27/NED |
| 2 | M/57 | Dysphonia | Glottis/RVC + AC | cT3N0 | OPHL 2B + ARY DX + RSND (II–IV) + IJV | 285 | pT3N1 | FU | 26/NED |
| 3 | M/79 | Dysphonia | Glottis/RVC + AC | cT3N0 | OPHL 2A + ARY DX + RSND (I–IV) | 180 | pT4aN0 | RT (rejected) | 25/DOD |
| 4 | M/59 | Dysphonia | Glottis/RVC | cT2N0 | OPHL 2A + RSND (II–IV) | 190 | pT2N0 | FU | 22/NED |
| 5 | M/63 | Dysphonia, Dysphagia | Supraglottis/infrahyoid epiglottis | cT3N0 | OPHL I + BSND (I–III) | 245 | pT3N0 | FU | 21/AWD |
| 6 | M/57 | Dysphonia | Glottis/LVC + AC | cT3N0 | OPHL 2B + BSND (II–IV) | 235 | pT4aN0 | RT | 21/NED |
| 7 | M/74 | Dysphonia | Glottis/RVC+AC | cT2N0 | OPHL 2A + RSND (II–IV) | 210 | pT2N0 | FU | 19/NED |
| 8 | M/70 | Dysphonia | Glottis/RVC+AC | cT3N0 | OPHL 2B + ARY DX + RSND (I–IV) | 140 | pT3N0 | FU | 17/DOC |
| 9 | F/67 | Dysphonia | Supraglottis | cT2N0 | OPHL I + | 195 | pT3N0 | FU | 17/NED |
| 10 | M/61 | Dysphonia | Glottis/RVC | cT2N0 | OPHL 2A + RSND (II–IV) | 170 | pT3N0 | FU | 16/NED |
| 11 | M/73 | Dysphonia | Glottis/LVC + AC | cT3N2a | OPHL 2B + ARY SIN + | 200 | pT3N2b | RT + CT | 15/NED |
| 12 | M/64 | Dysphonia | Supraglottis | cT3N0 | OPHL I + | 210 | pT3N0 | FU | 13/NED |
| 13 | F/68 | Dysphonia | Glottis/LVC | cT2N0 | OPHL 2A + ARY SN + LSND (II–IV) | 170 | pT2N0 | RT | 13/NED |
| 14 | M/79 | Dysphonia | Glottis/LVC + AC | cT3N0 | OPHL 2B + ARY SN + LSND (I–IV) | 190 | pT4aN0 | RT | 13/DOC |
| 15 | M/50 | Dysphonia | Glottis/RVC | cT2N0 | OPHL 2A + ARY DX + RSND (II–IV) | 205 | pT2N0 | RT | 11/NED |
| 16 | M/56 | Dysphonia | Glottis/AC | cT2N1 | OPHL 2B + BSND I–IV | 230 | pT2N2a | RT + CT | 11/NED |
| 17 | M/68 | Dysphonia | Glottis/LVC | cT3N0 | OPHL 2B + ARY SIN + LSND (II–IV) | 215 | pT3N0 | RT (perineural invasion) | 9/NED |
cTNM: clinical TNM; pTNM: pathological TNM; RVC: right vocal cord; AC: anterior commissure; LVC: left vocal cord; ARY: arytenoid; RSND: right selective neck dissection; IJV: internal jugular vein; LSND: left selective neck dissection; BSND: bilateral selective neck dissection; PO: post-operative; RT: radiotherapy; CT: chemotherapy; FU: follow-up; NED: no evidence of disease; DOD: died of disease; AWD: alive with disease; DOC: died for other cause.
Respiration and deglutition outcomes in enrolled patients.
| Case | Removal Tracheostomy Tube (Day P.O) | Start Oral Intake in Rehabilitation Protocol | Removal NGT (Day P.O) |
|---|---|---|---|
| 1 | 6 | 13 | 56 |
| 2 | 19 | 16 | 183 |
| 3 | 13 | 7 | (PEG) |
| 4 | 6 | 8 | 67 |
| 5 | 8 | 10 | 24 |
| 6 | 5 | 6 | 43 |
| 7 | 9 | 6 | 38 |
| 8 | 12 | 8 | 27 |
| 9 | 7 | 14 | 34 |
| 10 | 5 | 9 | 47 |
| 11 | - | 19 | 31 |
| 12 | 9 | 20 | 36 |
| 13 | 8 | 10 | 39 |
| 14 | 35 | 12 | 54 |
| 15 | 10 | 8 | 38 |
| 16 | 37 | 21 | 67 |
| 17 | 18 | 15 | 58 |
|
|
|
|
|
|
|
|
|
|
P.O: post-operative; NGT: nasogastric tube; PEG: percutaneous endoscopic gastrostomy; SD: standard deviation.
OPHL-PAS evaluation during the rehabilitation protocol.
| Case | PAS 15 Day PO (T1) | PAS 3 Months (T2) | PAS 6 Months (T3) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Liquid | Semisolid | Solid | Liquid | Semisolid | Solid | Liquid | Semisolid | Solid | |
| 1 | 3 | 3 | 5 | 3 | 3 | 6 | 2 | 1 | 3 |
| 2 | 6 | 7 | 7 | 5 | 6 | 7 | 5 | 5 | 5 |
| 3 | 8 | 7 | 7 | 7 | 7 | 7 | 7 | 4 | 5 |
| 4 | 3 | 4 | 6 | 2 | 2 | 4 | 2 | 2 | 1 |
| 5 | 4 | 4 | 5 | 5 | 4 | 5 | 3 | 2 | 3 |
| 6 | 3 | 5 | 4 | 4 | 5 | 4 | 3 | 3 | 2 |
| 7 | 5 | 3 | 2 | 3 | 2 | 3 | 4 | 3 | 1 |
| 8 | 7 | 3 | 4 | 5 | 3 | 3 | 5 | 2 | 2 |
| 9 | 7 | 5 | 6 | 4 | 4 | 4 | 5 | 3 | 3 |
| 10 | 5 | 6 | 6 | 4 | 3 | 3 | 3 | 4 | 2 |
| 11 | 4 | 7 | 5 | 4 | 4 | 3 | 4 | 4 | 1 |
| 12 | 8 | 6 | 6 | 7 | 5 | 4 | 6 | 3 | 1 |
| 13 | 6 | 5 | 7 | 6 | 5 | 5 | 5 | 3 | 2 |
| 14 | 5 | 6 | 4 | 5 | 4 | 3 | 4 | 5 | 2 |
| 15 | 7 | 8 | 4 | 6 | 6 | 4 | 6 | 4 | 1 |
| 16 | 6 | 7 | 4 | 4 | 6 | 4 | 6 | 4 | 2 |
| 17 | 8 | 7 | 4 | 6 | 6 | 3 | 6 | 4 | 2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
P.O: post-operative; PAS: penetration aspiration scale; SD: standard deviation.
Figure 2Open Partial Horizontal Laryngectomies-Penetration Aspiration Scale (OPHL-PAS) score values at three different observation point for liquids (A), semisolids (B) and solids (C). The asterisks represent the statistically significative difference between evaluation (** p < 0.001).
Phonation outcomes evaluated by VHI-10 of each patient.
| Case | VHI-10 | VHI-10 | VHI-10 |
|---|---|---|---|
| 1 | 19 | 17 | 17 |
| 2 | 17 | 16 | 13 |
| 3 | 23 | 23 | 17 |
| 4 | 15 | 16 | 12 |
| 5 | 16 | 11 | 9 |
| 6 | 15 | 16 | 12 |
| 7 | 21 | 20 | 16 |
| 8 | 19 | 19 | 14 |
| 9 | 19 | 17 | 12 |
| 10 | 17 | 14 | 11 |
| 11 | 18 | 15 | 10 |
| 12 | 16 | 13 | 13 |
| 13 | 22 | 19 | 15 |
| 14 | 17 | 14 | 12 |
| 15 | 13 | 13 | 8 |
| 16 | 14 | 12 | 10 |
| 17 | 16 | 16 | 12 |
|
|
|
|
|
|
|
|
|
|
P.O: post-operative; VHI: voice handicap index; SD: standard deviation.
Figure 3Voice Handicap Index-10 (VHI-10) score at three different observation points. The asterisks represent the statistically significative difference between evaluations (** p < 0.001).
Functional outcomes according to the type of OPHL.
| OPHL I | OPHL IIA | OPHL IIB | |
|---|---|---|---|
| Post-operative day removal tracheostomy tube (mean ± SD) | 8 ± 0.8 | 9.7 ± 2.4 | 18.6 ± 11.9 |
| Post-operative day removal NGT (mean ± SD) | 31.3 ± 5.2 | 45.8 ± 11.1 | 70.3 ± 47.2 |
| PAS liquid (mean ± SD) | 4.7 ± 1.2 | 4.5 ± 1.7 | 4.4 ± 1.4 |
| PAS semi-solid (mean ± SD) | 2.7 ± 0.5 | 3.3 ± 0.7 | 3.5 ± 1.3 |
| PAS solid (mean ± SD) | 2.3 ± 0.9 | 2 ± 1.4 | 2.6 ± 1.1 |
| VHI-10 (mean ± SD) | 11.3 ± 1.7 | 13.2 ± 3.1 | 12.5 ± 2.1 |
OPHL: Open Partial Horizontal Laryngectomies; NGT: nasogastric tube; PAS: Penetration Aspiration Scale; VHI: voice handicap index; SD: standard deviation.